| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.3M | +137.4% |
| R&D Expense | $119.5M | +15.1% |
| SG&A Expense | $54.2M | +14.6% |
| Operating Income | -$164.2M | -19.8% |
| Interest Expense | $13.3M | +0.2% |
| Pre-tax Income | -$147.8M | -75.9% |
| Income Tax | $0 | — |
| Net Income | -$147.8M | -75.9% |
| EPS (Basic) | -$2.12 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.7M | -20.0% |
| Accounts Receivable | $707K | -93.0% |
| Inventory | $385K | — |
| Current Assets | $123.5M | -22.6% |
| Total Assets | $269.8M | -17.4% |
| Current Liabilities | $60.8M | -9.4% |
| Total Liabilities | $201.9M | +7.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.5M | +0.8% |
| Capital Expenditures | $5.0M | -75.4% |
| Investing Cash Flow | $23.5M | -31.0% |
| Financing Cash Flow | $54.5M | -35.1% |
| Free Cash Flow | -$109.5M | +12.8% |
| -42.3% |
| EPS (Diluted) | -$2.12 | -42.3% |
| Stockholders' Equity |
| $67.8M |
| -50.9% |